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Abstract Hyaluronic acid (HA) is a glycosaminoglycan of the 
extracellular matrix. Its fragmentation by the hyaluronidase, 
secreted by tumor cells, facilitates tumor invasion and the HA 
degradation products generated stimulate angiogenesis. We 
report here that the HA-binding protein hyaluronectin (HN) 
inhibits the stimulatory effect of HA-derived fragments on the 
proliferation and migration of endothelial cells in vitro, and 
hampers the organization of endothelial cells into capillary-like 
structures. Since HN strongly inhibits endothelial cell adhesion 
to immobilized HA, it is postulated that HN acts by impairing 
the binding to endothelial cells of HA fragments generated by 
hyaluronidase, thereby neutralizing the effect of HA degradation 
products on angiogenesis. Our results reveal a new mechanism by 
which the angiogenesis induced by HA fragments is modulated by 
HN. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Angiogenesis is essential for many physiological and patho-
logical processes including wound healing, development, tissue 
repair and tumor growth [1]. In pre-existing micro vessels, the 
endothelial cell sprouting requires coordinated cell prolifera-
tion, migration, adhesion to the matrix and the degradation of 
matrix components [2,3]. For tumor angiogenesis, paracrine 
stimulation of the endothelial cells is provided by growth fac-
tors and matrix proteins. Hyaluronan or hyaluronic acid (HA) 
is a major glycosaminoglycan of the extracellular matrix. Con-
siderable evidence has indicated that HA plays a role in mod-
ulating the growth of new vessels. For example, the degrada-
tion of HA by testicular hyaluronidase has been shown to 
accelerate the wound healing in an animal model and the 
degradation products of HA had angiogenic activity in vitro 
and in vivo in a chick chorioallantoic membrane model while 
degradation products of chondroitin sulfate are devoid of ef-
fects [4]. Over-expression of hyaluronidase by tumor cells in-
creased new vessel formation around the tumor implants with-
in the mouse cornea [5]. A great amount of HA was produced 
by malignant brain tumors and the level of HA positively 
correlated with the malignancy of the tumor [6]. This angio-
genic activity of hyaluronidase could be attributed to the deg-
radation products of HA since semi-purified fragments of 
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6-20 saccharide units (HA 6-HA 20) of hyaluronidase-de-
graded HA were the most potent stimulators of proliferation 
and migration of endothelial cells whereas native high molec-
ular weight HA was inactive [7-9]. In addition, hyaluronan 
degradation products and vascular endothelial growth factor 
(VEGF) exerted a synergistic effect on endothelial cell prolif-
eration and capillary formation in vitro [10]. However the 
molecular mechanism for endothelial cell activation by HA 
degradation products is still unclear. Previously we have 
shown that anti-CD44 antibody J 173 inhibits the stimulating 
effect of HA degradation products on endothelial cells sug-
gesting that the effect of HA fragments on the cells may be 
partially mediated by the HA receptor CD44 [9]. 
Hyaluronectin (HN) is a matrix protein which binds specif-
ically HA and HA fragments (Kd = 4.5 X 10~
9) in vitro [11,12]. 
HN was observed in the extracellular matrix of nerve tissue 
tumors and also non-nervous system tumors. Using both im-
munological studies and Northern blot analysis, HN present 
in tumors was shown to derive from many different sources 
including fibroblasts around capillaries, activated monocytes 
and probably endothelial cells themselves [13,14]. Because HA 
was localized at the perivascular zone in a tumor, together 
with HN [6], it was supposed that HA and HN would also 
interact in vivo. However, the significance of the colocaliza-
tion of HN and HA in tumor tissue remains unclear. There-
fore, it was of obvious interest to elucidate whether HN-HA 
interaction could modulate the angiogenic properties of HA 
fragments by competing with HA binding to cells. Thus, this 
study aims to clarify the effect of HN on the angiogenic ac-
tivity of purified HA degradation products in an in vitro sys-
tem. 
2. Material and methods 
Purified HA from human umbilical cord and hyaluronidase from 
bovine testes were obtained from Sigma (St. Louis, MO, USA). Sheep 
brain HN was prepared as previously described [12,15]. Briefly, a 
sheep brain was homogenized in 0.2 M glycine HC1 pH 2.2. After 
centrifugation, the supernatant was dialysed with PBS and applied to 
an HA-Sepharose affinity chromatography column and the adsorbent 
was eluted with 0.2 M glycine HC1, pH 2.8. The elute contains highly 
purified HN (purity grade > 98%). HA degradation products were 
obtained by digesting HA with hyaluronidase at 37°C for 6 h followed 
by an isolation on an Ac A 202 gel chromatography column. 
2.1. Cell culture 
CPAE (calf pulmonary artery endothelial cells) were provided by 
Dr. J. Badet (Laboratoire de Biotechnologie des cellules eucaryotes, 
Universite de Creteil, France). These cells were cultured in MEM 
medium supplemented with 20% FCS, 2 mM L-glutamine, 100 IU/ 
ml penicillin, and 100 (ig/ml streptomycin (Gibco, Paisley, UK) and 
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used at passage 12-20. HMEC-1 (human microvascular endothelial 
cells) was provided by Dr. Ades (Center for Disease Control and 
Prevention, Atlanta, GA, USA) who established this cell line by trans-
fecting human dermal endothelial cells with SV40 A gene product and 
large T antigen [16]. HMEC-1 were cultured with MCDB 131 medium 
(Sigma) supplemented with 10% FCS, 2 mM L-glutamine, 100 IU/ml 
penicillin, 100 ug/ml streptomycin, 10 ng/ml EGF (Collaborative Bio-
medical Products) and 1 mg/ml hydrocortisone streptomycin, 10 ng/ml 
EGF (Collaborative Biomedical Products) and 1 mg/ml hydrocorti-
sone (Sigma). 
2.2. Cell proliferation assay 
CPAE were trypsinized and cultured at 1400 cells per well in 96-well 
plates in complete medium (MEM) containing 20% FCS. After 24 h, 
the cells were cultured in the same medium with 5% FCS to induce the 
cells to accumulate at the G0-G1 proliferation stage for another 24 h. 
For the proliferation assay, the cells were further cultured for 30 h in 
fresh medium containing 20% FCS, in the presence of various agents 
such as HN (5 ug/ml or 100 ug/ml), HA (10 ug/ml), its degradation 
fragments HA-12 (0.5 |ig/ml) or hyaluronidase (50 |xg/ml). 
[3H]Thymidine (1 uCi per well) was then added to the cells to allow 
[3H]thymidine to incorporate for 18 h. For quantification, incorpo-
rated [3H]thymidine was absorbed onto a filter paper with a Skatron 
harvester (Skatron, Lier, Norway) and the radioactivity was deter-
mined in a liquid scintillation counter. Triplicate experiments were 
repeated at least five times. The results are expressed as the percentage 
of the controls. 
2.3. Migration assay of endothelial cells 
The migration assay was performed in 24-well culture plates, as 
previously described [9]: first, 1.2% agarose was dissolved in the cul-
ture medium to form a gel in the wells. Half of the agarose cylinder 
was then cut off from each well. CPAE cells were added into the 
empty part of the wells and cultured until confluence. Then the re-
maining agarose gel filling the other half of the well was removed to 
allow cell migration towards the resulting free space, and various 
agents including HN, the HA-derived 12 oligosaccharides or hyalur-
onidase were added at indicated concentrations. Then transparent 
graph paper was stuck to the bottom of the culture plates to allow 
the measurement of the cell migration into the half vacant part of the 
culture well. The results of the migration distance were expressed as 
the percentage of the migration rate of the control cells. The experi-
ments were repeated at least five times. 
2.4. Formation of capillaries in two models of angiogenesis in fibrin gels 
The first model using aggregates of CPAE was devised according to 
the method of Pepper et al. [17] and details of experiment were de-
scribed by Trochon et al. [9], The second model with microcarrier 
beads was devised according to the method of Nehl et al. [18]. Briefly 
HMEC-1 were allowed to attach to the Cytodex-3 microcarrier beads 
(Sigma) by incubating cells with beads in complete medium with 10% 
FCS during 4 h at 37°C. The microcarrier beads were then suspended 
in a larger volume of the same medium and then agitated for 5 min 
every 30 min at 30 rpm/min during the first 12 h, followed by culture 
with continuous stirring for 4 days. When the whole surface of the 
microcarrier beads was covered with endothelial cells, they were con-
centrated by centrifugation for 5 min at 800 Xg at room temperature 
and embedded in a fibrin matrix. Fibrin matrix was prepared as fol-
lows: purified fibrinogen at 3 mg/ml (Kabi, Stockholm, Sweden) was 
dialyzed against MCDB 131 and then mixed with FCS (10%), gluta-
mine (1%), penicillin/streptomycin (l%o) and aprotinin (2 uM). Human 
thrombin at 1 IU/ml was added to the fibrinogen solution. Once a 
fibrin gel had formed, 500 ul of complete culture medium containing 
2 uM aprotinin was added on the surface of the fibrin matrix and this 
was changed every 3 days. Formation of capillary tubes arising from 
the periphery of microcarrier beads could be observed from the begin-
ning of 4 days culture. These capillaries were photographed with a 
camera on a reverse microscope and their lengths were measured on 
the pictures. Statistical analysis (Mann-Whitney method) was per-
formed to test if the length of capillaries was different. 
2.5. Adhesion to hyaluronic acid 
96-well plates (Greiner, D. Dutcher) were coated with 100 ul HA 
(1 mg/ml in distilled water; Sigma) overnight at room temperature. 
Negative controls consisted of wells coated with 2%> bovine serum 
7 
albumin in PBS for 2 h at 37°C. Plates were washed three times 
with 100 (xl PBS containing 2%> BSA and then three times with 100 
|xl PBS. HMEC-1 were detached from culture flasks by incubation 
with 1.5 mM EDTA and resuspended to a final concentration of 
5X105 cells/ml in an adhesion buffer: NaCl 140 mM, HEPES 10 
mM, glucose 5.56 mM, KC1 5.4 mM, CaCl2 2 mM, MgCl2 1 mM, 
MnCl2 1 mM, 1%. BSA, pH 7.4. For inhibition studies, the HA-coated 
wells were preincubated with 60 ul HN (2 mg/ml) for 10 min at room 
temperature. Then, 100 JJ.1 HMEC-1 suspension were added to the 
wells and incubated for 20 min at 37°C. Non-adherent cells were 
removed by washing the wells three times with 200 ul adhesion buffer 
plus 1%) BSA. The measurement of cell phosphatase activity was used 
to quantify adherent cells. Briefly, 100 ul of paranitrophenylphosphate 
(Sigma) at 3 mg/ml in acetate buffer pH 5.5 containing 0.1%> Triton X-
100, were added to the wells and incubated for 2 h at 37°C. The 
reaction was then stopped by 1 N NaOH. Released paranitrophenol, 
that indicates the adherent cell number, was measured by reading the 
adsorbance at 405 nm in an ELISA reader (Titertek Twinreader). 
Non-specific binding on BSA-coated plates was subtracted from the 
data. Results are expressed as the percentage of cells adherent to HA-
coated wells in the absence of HN. All experiments were performed in 
triplicate. 
3. Results 
3.1. Stimulation of endothelial cell proliferation by 
hyaluronidase and HA degradation fragments 
Hyaluronidase (50 |xg/ml) caused an approximately twofold 
increase in the proliferation of CPAE. This could be due to 
the production of fragments from H A contained in the FCS 
and constitutively secreted by the endothelial cells. To further 
verify this, we used the purified H A degradation products 
(HA-12) to stimulate endothelial cells. As shown in Fig. 1, 
HA-12 induced proliferation of the endothelial cells (maximal 
effect was reached at 0.5 ng/ml, with a 46% increase). In con-
trast, undegraded H A had no effect even at a concentration as 
high as 10 ng/ml. Addit ion of exogenous H A (5-15 ng/ml) 
together with 50 (J.g/ml hyaluronidase did not enhance the 
effect of hyaluronidase on the endothelial cell response. These 
results suggested that the endogenous H A concentration in 
culture medium (0.15 |4,g/ml) is high enough for the generation 
of H A fragments with the maximal effect. In addition, hya-
luronidase treatment may destroy the cell surface H A coat, 
thereby exposing of H A receptors. Consequently, hyaluroni-
dase induced a more pronounced cell proliferation than that 
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Fig. 1. Effects of hyaluronidase and HA-12 on CPAE proliferation. 
CPAE were cultured for 24 h with 5%> FCS and further cultured 
for 30 h in the same medium containing 20% FCS in the absence 
or presence of hyaluronidase (50 |ig/ml) or HA-12 (0.5 ug/mi) 
or undegraded HA (10 ug/ml)+hyaluronidase (50 ug/ml). Then 
[3H]thymidine was added to the cells for a further 18 h incubation 
and incorporated [3H]thymidine was measured. Data from five ex-
periments. Means ± S.E.M., n = 6. 
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Table 1 
Effects of HN on hyaluronidase and HA-12-induced endothehal cell proliferation and migration 
Cell proliferation (% of control) 
[3H]thymidine incorporation 
Cell migration rate 
(% of control) 
Control 
HA-12 (0.5 ug/ml) 
HA-12 (0.5 ug/ml)+HN (5 ug/ml) 
Hase (50 ug/ml) 
Hase (50 ug/ml)+HN (100 ug/ml) 
Hase (50 ug/ml)+HA (10 ug/ml) 















The migration and proliferation assays were performed for CPAE cells as described in Section 2. The data were from at least five experiments. 
Means ± S.E.M. 
3.2. Neutralization by HN of the stimulation of endothehal cell 
proliferation and migration induced by hyaluronidase and 
HA-12 
Next we studied the effect of HN on endothelial cell pro-
liferation and migration, HN (5 Ug/ml) neutralized the stim-
ulating effect of 0.5 ug/ml HA-12 both on endothelial cell 
proliferation and migration (Table 1). This concentration of 
HN used was chosen because it was previously shown that a 
10-fold excess (w/w) was necessary to saturate free HA [19,20]. 
In the same manner, HN (100 |xg/ml) abolished the stimulat-
ing effect induced by 50 ug/ml hyaluronidase. Indeed, lower 
concentrations of HN did not show any significant effect. 
Moreover, 100 ng/ml neutralized the stimulating effect in-
duced by the addition of hyaluronidase (50 u.g/ml) plus HA 
(10 u,g/ml) on cell proliferation. Thus, a 20-fold higher con-
centration of HN was required to neutralize the effect of hya-
luronidase in comparison with the concentration needed to 
neutralize the effect of HA fragments. It may imply that dur-
ing the degradation of cell-associated HA by hyaluronidase, 
the HA fragments produced immediately bound to cell recep-
tor^) with a high efficiency, therefore reducing the efficiency 
of HN in these neutralizing assays. 
endothelial cell-linked, hollow tube-like structures was ob-
served. HN at 20 |Xg/ml incorporated into the fibrin gel re-
duced the length of tubes around the microcarrier beads (Fig. 
3). The difference was more obvious after 20 days incubation. 
Addition of HN induced 34.6% reduction of the mean tube 
length (P<0.05, data from 15 microcarrier beads for each 
condition). Higher concentrations of HN had not shown 
more pronounced effects in two models described (results 
not shown). Finally, this inhibition of angiogenesis induced 
by HN is not due to an artefact related to a modification of 
the fibrin gel as we have checked that thrombin clotting time 
and fibrin polymerization curves showed no difference in the 
presence or absence of HN (data not shown). 
3.4. Inhibition of endothelial cell adhesion to HA-coated plates 
by hyaluronectin 
The possibility that HN neutralizes the stimulatory effect of 
HA fragments by interrupting the binding of HA fragments to 
cells was finally tested in a cell adhesion assay. In our con-
ditions, HN (120 |Xg/ml) significantly reduced cell adhesion to 
HA-coated wells by 45 ± 4.9%. Further increase in concentra-
tions of HN did not increase the effect. 
3.3. Inhibition of capillary tube formation by hyaluronectin in 
two models using fibrin matrix with CPAE or HMEC-1 
One of models used was established as described by Pepper 
et al. [17]. Embedding the aggregates of CPAE in the fibrin gel 
gave rise to the formation of endothelial-lined sacs with capil-
lary-like tubes after 2 days. As shown in Fig. 2, addition of 
HN at 20 |xg/ml to the fibrin gel resulted in a reduction of the 
length of tubes around the CPAE aggregates by 41.2% de-
crease after 4 days incubation (i><0.05, data from 10 aggre-
gates in each groups). 
The second model used was described by Nehls et al. [18]. 
Microcarrier beads seeded with HMEC-1 were embedded in 
the fibrin gel. After 4 days culture, the formation of small, 
4. Discussion 
Hyaluronidase secreted by tumor cells is believed to be an 
important factor in tumor growth and metastasis. Recently, it 
was shown that hyaluronidase PH-20, similar to the one 
present on human sperm (testicular hyaluronidase), expressed 
on tumor cells may participate in the induction of angiogen-
esis [5]. Here, we present evidence that testicular hyaluroni-
dase induces the proliferation and migration of vascular en-
dothelial cells, and this could explain the angiogenic effect of 
hyaluronidase in vivo. A similar action was seen with frag-
ments of HA while undegraded HA was devoid of effect. HN, 
which exhibits a strong and specific affinity for HA (Kd 
Fig. 2. Effect of HN on endothelial cell capillary formation in a fibrin matrix using CPAE. Phase contrast views of CPAE aggragates in fibrin 
gels, 4 days after embedding in the absence (A) or in the presence (B) of HN at 20 ug/ml. 
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Fig. 3. Effect of HN on endothelial cell capillary formation using HMEC-1. Microcarrier beads covered with endothelial cells were embedded 
in a fibrin matrix in the absence or presence of HN (20 ug/ml). A: Control (4 days); B: HN (4 days); C: control (20 days); D: HN (20 days). 
5.4 XlO - 9 M) and HA fragments [12,19], is a glycoprotein 
synthesized by the tumors stromal cells and secreted into the 
extracellular matrix. This association between HA and HN in 
vitro may occur also in vivo because a similar histological 
colocalization of HA and HN in brain tumors was observed 
[6]. Therefore, it was logical to test whether HN may modu-
late the effect of HA fragments on angiogenesis. 
This effect of HN was studied on proliferation and migra-
tion of endothelial cells and on capillary tube formation, three 
steps essential for angiogenesis. HN inhibited the effect of 
HA-12 on endothelial cell proliferation and to a lesser extent 
on endothelial cell migration; it also inhibited HA-12-induced 
capillary tube formation (not shown). HN also inhibited the 
combined effect of HA+hyaluronidase on endothelial cell pro-
liferation. Until now, precise concentrations of HA fragments, 
HN and hyaluronidase have not been available for normal 
complete culture medium. However, we deduced from our 
results that HA is usually in excess over HN, thus a large 
number of HA fragments could be produced by exogenously 
added hyaluronidase and a trace amount of HN present in 
culture medium is not sufficient to counterbalance this effect. 
A 10-fold excess of HN (w/w) was required to neutralize the 
action of HA fragments as previously indicated [20]. However, 
higher concentrations of HN were needed for neutralizing the 
action of hyaluronidase than that of HA-12. This difference 
may not be surprising because in our experimental conditions, 
the action of added HA fragments could be hampered by 
endogenous HA coating the cells. In contrast, the addition 
of hyaluronidase, by degrading HA, could result in the expo-
sure of free HA binding receptor(s) on the cell surface and 
concomitantly, in the production of available HA fragments 
in close vicinity. The high concentration of HN needed for 
angiogenesis inhibition does not exclude a physiological sig-
nificance of HN because of its accumulation in the matrix 
around the vessels causing local high level of HN, as shown 
by histological studies [6]. 
Since HN does not inhibit the degradation of HA by hya-
luronidase (not shown), it is postulated that HN acts by in-
hibiting the binding to endothelial cells of HA fragments gen-
erated by hyaluronidase, so that their effect on angiogenesis 
would be blocked. The inhibition of HA binding to endothe-
lial cells receptors by HN is also suggested by our results 
showing that HN strongly inhibits endothelial cell adhesion 
to immobilized HA. 
Hitherto, angiogenesis was believed to depend on the bal-
ance between positive and negative factors in the tumor [21]. 
Our results reveal a new mechanism by which the angiogenesis 
induced by HA fragments is modulated by HN. Angiogenesis 
could therefore proceed by either an increase in the produc-
tion of HA degradation products due to a hyaluronidase ex-
cess and/or a decrease in HN production. This view is sup-
ported by the observations that HN levels are particularly low 
in the more malignant brain tumors (glioblastoma grade III 
and IV) compared to normal brain or astrocytoma that ex-
hibit relatively low invasive and angiogenic properties [6]. 
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